BCLI - BrainStorm Cell Therapeutics GAAP EPS of -$0.29 misses by $0.15
2023-11-14 07:07:42 ET
More on BrainStorm Cell Therapeutics
- Brainstorm Cell Therapeutics: I Anticipate A Positive AdCom But There Are Major Risks
- Brainstorm realigns resources to support NurOwn development
- Brainstorm to pull marketing application for ALS therapy
- Seeking Alpha’s Quant Rating on BrainStorm Cell Therapeutics
- Historical earnings data for BrainStorm Cell Therapeutics
For further details see:
BrainStorm Cell Therapeutics GAAP EPS of -$0.29 misses by $0.15